Molecular pathways behind acquired obesity: Adipose tissue and skeletal muscle multiomics in monozygotic twin pairs discordant for BMI.


Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 09 10 2020
revised: 31 12 2020
accepted: 04 03 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 6 5 2021
Statut: epublish

Résumé

Tissue-specific mechanisms prompting obesity-related development complications in humans remain unclear. We apply multiomics analyses of subcutaneous adipose tissue and skeletal muscle to examine the effects of acquired obesity among 49 BMI-discordant monozygotic twin pairs. Overall, adipose tissue appears to be more affected by excess body weight than skeletal muscle. In heavier co-twins, we observe a transcriptional pattern of downregulated mitochondrial pathways in both tissues and upregulated inflammatory pathways in adipose tissue. In adipose tissue, heavier co-twins exhibit lower creatine levels; in skeletal muscle, glycolysis- and redox stress-related protein and metabolite levels remain higher. Furthermore, metabolomics analyses in both tissues reveal that several proinflammatory lipids are higher and six of the same lipid derivatives are lower in acquired obesity. Finally, in adipose tissue, but not in skeletal muscle, mitochondrial downregulation and upregulated inflammation are associated with a fatty liver, insulin resistance, and dyslipidemia, suggesting that adipose tissue dominates in acquired obesity.

Identifiants

pubmed: 33948567
doi: 10.1016/j.xcrm.2021.100226
pii: S2666-3791(21)00042-2
pmc: PMC8080113
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Twin Study

Langues

eng

Pagination

100226

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL028481
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095056
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK105561
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Obes Rev. 2015 Sep;16(9):715-57
pubmed: 26179344
Curr Protoc Mouse Biol. 2017 Jun 19;7(2):130-143
pubmed: 28628219
Rev Endocr Metab Disord. 2014 Dec;15(4):277-87
pubmed: 25344447
Nat Rev Endocrinol. 2020 Aug;16(8):421-436
pubmed: 32493980
Acta Physiol Scand. 1967 Oct-Nov;71(2):140-50
pubmed: 5584523
Twin Res Hum Genet. 2019 Aug;22(4):240-254
pubmed: 31462340
Anal Chem. 2011 Sep 15;83(18):7074-80
pubmed: 21830798
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Biochem Biophys Res Commun. 2017 Jan 8;482(2):282-288
pubmed: 27847319
Nucleic Acids Res. 2013 Apr;41(8):4378-91
pubmed: 23444143
J Proteomics. 2015 Nov 3;129:108-120
pubmed: 26381204
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Biochem J. 2016 Jul 15;473(14):2187-203
pubmed: 27208167
Nat Biotechnol. 2014 Mar;32(3):219-23
pubmed: 24727770
Exp Mol Med. 2018 Sep 28;50(9):1-14
pubmed: 30266947
Diabetes. 2019 Dec;68(12):2247-2258
pubmed: 31492661
Int J Obes (Lond). 2017 Aug;41(8):1176-1184
pubmed: 28439093
Sci Signal. 2020 Mar 24;13(624):
pubmed: 32209698
PLoS One. 2017 Jun 1;12(6):e0178485
pubmed: 28570579
Biochem J. 2003 Nov 1;375(Pt 3):539-49
pubmed: 18320708
Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Nat Rev Endocrinol. 2017 Nov;13(11):633-643
pubmed: 28799554
Nat Cell Biol. 2018 Jul;20(7):745-754
pubmed: 29950572
Diabetes. 2016 Sep;65(9):2724-31
pubmed: 27207528
Twin Res Hum Genet. 2019 Oct;22(5):302-311
pubmed: 31640839
PLoS One. 2016 Dec 1;11(12):e0167519
pubmed: 27907186
Acta Physiol (Oxf). 2020 Jan;228(1):e13298
pubmed: 31077538
Diabetes. 2011 Mar;60(3):1019-29
pubmed: 21266331
Gastroenterology. 2009 Sep;137(3):865-72
pubmed: 19524579
Obes Rev. 2020 Feb;21(2):e12958
pubmed: 31777187
PLoS Med. 2008 Mar 11;5(3):e51
pubmed: 18336063
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085992
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Diabetologia. 2012 Apr;55(4):1114-27
pubmed: 22282162
Cell Rep. 2015 May 12;11(6):921-933
pubmed: 25937284
Int J Obes (Lond). 2015 May;39(5):869-73
pubmed: 25520251
Mol Syst Biol. 2013;9:649
pubmed: 23511207
J Clin Endocrinol Metab. 2016 Apr;101(4):1455-68
pubmed: 26789776
Elife. 2019 Jul 18;8:
pubmed: 31305240
Int J Biochem Cell Biol. 2017 Jul;88:23-30
pubmed: 28465089
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717
pubmed: 22261725
Sci Rep. 2017 Oct 23;7(1):13850
pubmed: 29062026
Mol Syst Biol. 2018 Aug 13;14(8):e8126
pubmed: 30104418
Diabetes. 2010 Jan;59(1):33-42
pubmed: 19833877
Mol Cell Endocrinol. 2014 Aug 25;394(1-2):80-7
pubmed: 25011057
Genome Med. 2017 May 25;9(1):47
pubmed: 28545587
Twin Res Hum Genet. 2019 Dec;22(6):530-539
pubmed: 31796134
J Cell Biol. 2015 Mar 2;208(5):501-12
pubmed: 25733711
Front Endocrinol (Lausanne). 2020 Feb 21;11:73
pubmed: 32153509
J Magn Reson. 1997 Nov;129(1):35-43
pubmed: 9405214
Genomics Proteomics Bioinformatics. 2007 Dec;5(3-4):216-35
pubmed: 18267303
Am J Hum Genet. 2012 Nov 2;91(5):839-48
pubmed: 23103226
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Sci Data. 2014 Sep 16;1:140031
pubmed: 25977788
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Nature. 2011 Nov 20;481(7381):385-8
pubmed: 22101431
Obesity (Silver Spring). 2015 May;23(5):981-988
pubmed: 25864501
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
OMICS. 2015 Sep;19(9):563-73
pubmed: 26348713
Nat Commun. 2016 Jun 29;7:11764
pubmed: 27353450
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100
pubmed: 31636403
Sci Rep. 2016 Apr 15;6:24540
pubmed: 27080554
Cell Metab. 2017 Oct 3;26(4):693
pubmed: 28978428
Nucleic Acids Res. 2013 Jan;41(Database issue):D801-7
pubmed: 23161693
Nat Rev Rheumatol. 2014 May;10(5):295-303
pubmed: 24468934
J Clin Invest. 2017 Jan 3;127(1):43-54
pubmed: 28045398
Am J Clin Nutr. 1982 Nov;36(5):936-42
pubmed: 7137077
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10
pubmed: 24731669
Diabetes. 2005 May;54(5):1283-8
pubmed: 15855311
Front Cell Dev Biol. 2017 Dec 07;5:106
pubmed: 29270406
Diabetes. 2015 Sep;64(9):3135-45
pubmed: 25972572
Cell Rep. 2016 Aug 30;16(9):2317-26
pubmed: 27545890
Obesity (Silver Spring). 2018 Dec;26(12):1870-1878
pubmed: 30369078
BMC Med Genomics. 2012 Apr 03;5:9
pubmed: 22471940
Curr Protoc Bioinformatics. 2019 Dec;68(1):e86
pubmed: 31756036
Int J Obes (Lond). 2014 Nov;38(11):1423-31
pubmed: 24549139
Diabetologia. 2017 Oct;60(10):2052-2065
pubmed: 28770317

Auteurs

Birgitta W van der Kolk (BW)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Sina Saari (S)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Alen Lovric (A)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.
Division of Clinical Physiology, Department of Laboratory Medicine, Karolinska Institutet and Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.

Muhammad Arif (M)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.

Marcus Alvarez (M)

Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Arthur Ko (A)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Zong Miao (Z)

Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA.

Navid Sahebekhtiari (N)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Maheswary Muniandy (M)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Sini Heinonen (S)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Ali Oghabian (A)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Riikka Jokinen (R)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Sakari Jukarainen (S)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.

Antti Hakkarainen (A)

HUS Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Jesper Lundbom (J)

HUS Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany.

Juho Kuula (J)

HUS Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.

Per-Henrik Groop (PH)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.

Taru Tukiainen (T)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.

Nina Lundbom (N)

HUS Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Aila Rissanen (A)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Jaakko Kaprio (J)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.

Evan G Williams (EG)

Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Nicola Zamboni (N)

Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Adil Mardinoglu (A)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.
Centre for Host-Microbiome Interactions, Dental Institute, King's College London, London, UK.

Päivi Pajukanta (P)

Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA.
Institute for Precision Health, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Kirsi H Pietiläinen (KH)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Obesity Center, Abdominal Center, Helsinki University Hospital, Helsinki, Finland.

Articles similaires

Humans Meals Time Factors Female Adult
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Classifications MeSH